LOU064
CAS: 1787294-07-8
Ref. 3D-FL171925
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Informação sobre produto
- REMIBRUTINIB
- N-(3-{5-[2-(Acryloyl-methyl-amino)-ethoxy]-6-amino-pyrimidin-4-yl}-5-fluoro-2-methyl-phenyl)-4-cyclopropyl-2-fluoro-benzamide
- Benzamide, N-[3-[6-amino-5-[2-[methyl(1-oxo-2-propen-1-yl)amino]ethoxy]-4-pyrimidinyl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluoro-
- LOU-064
LOU064 is a covalent inhibitor of tyrosine kinases that binds to the ATP site of the enzyme. It has been shown to be effective in treating autoimmune diseases and inflammatory diseases in animal models, but has not yet been tested in humans. LOU064 is a reversible covalent inhibitor, meaning it can bind to tyrosine kinase enzymes and inhibit their activity without causing irreversible damage. This drug also shows selectivity for certain protein targets, such as epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), and human epidermal growth factor receptor 2 (HER2). LOU064 has not been linked to any serious adverse side effects and does not appear to have any negative impact on the immune system.
Propriedades químicas
Consulta técnica sobre: 3D-FL171925 LOU064
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
